BIOS Capital Management, LP Long-Term Concentrated

Location: Fort Worth, TX

CIK: 0001813845 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 13, 2026

Total Value: $82.62M (100.0% shares, 0.0% debt)

Holdings (6)

ACTU ACTUATE THERAPEUTICS INC 74.4%

Value $61.51M Shares 10,049,996 Est. Cost $8.16 Unrealized -15.8%

CGTX COGNITION THERAPEUTICS INC 9.8%

Value $8.1M Shares 6,000,000 Est. Cost $0.49 Unrealized +228.3%

IRD OPUS GENETICS INC 9.0%

Value $7.404M Shares 3,683,429 Est. Cost $0.99 Unrealized +105.9%

LTRN LANTERN PHARMA INC 3.7%

Value $3.059M Shares 1,009,507 Est. Cost $3.42 Unrealized +8.7%

RNTX REIN THERAPEUTICS INC 2.4%

Value $1.961M Shares 1,690,751 Est. Cost $3.03 Unrealized -54.5%

INAB IN8BIO INC 0.7%

Value $593K Shares 253,417 Est. Cost $1.90 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACTU	ACTUATE THERAPEUTICS INC	10,049,996	$61.51M	74.4%	$8.16	-15.8%	COM	005083100
CGTX	COGNITION THERAPEUTICS INC	6,000,000	$8.1M	9.8%	$0.49	+228.3%	COM	19243B102
IRD	OPUS GENETICS INC	3,683,429	$7.404M	9.0%	$0.99	+105.9%	COM	67577R102
LTRN	LANTERN PHARMA INC	1,009,507	$3.059M	3.7%	$3.42	+8.7%	COM	51654W101
RNTX	REIN THERAPEUTICS INC	1,690,751	$1.961M	2.4%	$3.03	-54.5%	COM NEW	00887A204
INAB	IN8BIO INC	253,417	$593K	0.7%	$1.90	0.0%	COM NEW	45674E208